Preclinical and Clinical In-Licensing Project Leader F/M

Department : R&D
Reference : PCILPL241016
Date : 25/10/2016
Place : Suresnes

Based in our Head Office, Paris area, France


Within our R&D and under the supervision of the Cardiovascular Opportunities Director, the Preclinical and Clinical In-Licensing Project Leader is in charge of:

- participating in the evaluation of external licensing-in opportunities at all stages;

- taking part in due diligence of new molecules as the clinical referent;

- increasing the number of opportunities to be evaluated through proactive participation to Congress Meetings and development of a relevant network;

- taking part in the evaluation and implementation of new orientations for the cardiovascular licensing-in strategy;

- ensure reporting and global support to the multidisciplinary orientation group organized within the structure.



- Medical Doctor specialized in Cardiology or with a solid background in this field within the pharmaceutical industry;

- Minimum of 10 years of relevant experience, with at least 5 years in an international pharmaceutical company (preferably R&D, scientific background, experience in Marketing can be an additional asset) ;

- Perfect fluency in English (knowledge of French is an advantage).

Additional expectations:

- Reactivity and dynamism

- Precision and rigor

- Enthusiasm, strong motivation and dedication

- Business approach and extensive comprehension of the pharmaceutical market challenges

Advantages for the candidate:

- Extremely rewarding and visible position, adapted to a candidate who wishes to learn, advance and develop his career quickly;

- Opportunity to proactively participate in the development and evolution of the portfolio of an important pharmaceutical company;

- Everyday missions which allow to associate business and science;

- Development of personal contacts and network.

If you are a motivated and talented professional with the required skills for this position and wish to join a stimulating work environment while contributing to the development of innovative treatments, send us your application.